Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | KRT5 |
| Upstream (Parents) |
|---|
| (<<) DSC1 → KRT5 |
| (<<) KRT14 → KRT5 |
| (<<) LGALS7B///LGALS7 → KRT5 |
| (<<) CLCA2 → KRT5 |
| (<<) S100A7 → KRT5 |
| (<<) CSTA → KRT5 |
| (<<) GPR87 → KRT5 |
| (<<) LY6D → KRT5 |
| Downstream (Children) |
|---|
| KRT5 → CD207 (>>) |
| KRT5 → PFDN4 (>>) |
| KRT5 → UTS2 (>>) |
| KRT5 → KRT14 (>>) |
| KRT5 → LGALS7B///LGALS7 (>>) |
| KRT5 → CLCA2 (>>) |
| KRT5 → S100A7 (>>) |
| KRT5 → SPTA1 (>>) |
| KRT5 → ANAPC13 (>>) |
| KRT5 → GPR87 (>>) |
| KRT5 → LY6D (>>) |
